Status:
RECRUITING
Reproductive and Mental Health of Patients With Aplastic Anemia
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Conditions:
Aplastic Anemia
Reproductive Health
Eligibility:
All Genders
18-40 years
Brief Summary
Aplastic anemia (AA) is a hematological disease characterized by bone marrow failure, leading to varying degrees of anemia, leukopenia, and thrombocytopenia. With the advancement of immunosuppressive ...
Eligibility Criteria
Inclusion
- Diagnosis of AA
- Male or female, aged 18-40 years
- ECOG performance status ≤2
- Willing and able to comply with the requirements for this study and written informed consent
Exclusion
- Diagnosis of inherited bone marrow failure syndromes
- Combined with other hematological diseases
- Chemotherapy-induced bone marrow failure
- Pregnant or breastfeeding women
- Subjects with a history of mental illness or severe psychological disorders
- Subjects with a history of reproductive system cancer (eg, penile cancer, testicular cancer, prostate cancer, ovarian cancer, cervical cancer, vaginal cancer, etc.)
- Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study
Key Trial Info
Start Date :
March 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06936930
Start Date
March 3 2025
End Date
December 31 2027
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regenerative Medicine Center
Tianjin, Tianjin Municipality, China, 301617